Case Report
Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Immune-Mediated Necrotizing Myopathy following mRNA SARS-CoV-2 Vaccination
Table 1
Published reports of immune-mediated necrotizing myositis and previous vaccination.
| Authors | Year | Age | Sex | Time from vaccination to symptom onset | Vaccine | Treatment |
| Cavalcanti et al. [18] | 2021 | 42 | Female | 2 weeks | Yellow fever, tetanus/diphtheria, and hepatitis B | Prednisone 1 mg/kg/day | Dodig et al. [19] | 2021 | 55 | Female | 21 days after 2nd dose | Pfizer-BioNTech (BNT162b2 mRNA) | Prednisone 30 mg twice; IVIG 1 g/kg; methotrexate 12.5/25 mg daily | Tan et al. [20] | 2021 | 54 | Male | 1 week after 2nd dose | CoronaVac (Sinovac Biotech) | IVIG 2 g/kg followed by oral prednisolone 60 mg daily |
|
|
IVIG: intravenous immunoglobulin.
|